MASSACHUSETTS FINANCIAL SERVICES CO /MA/
Position in VNDA — Vanda Pharmaceuticals Inc.
CIK 912938
Boston, MA
Position in VNDA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$601,870
-$94,333 QoQ
Shares Held
98,345
-2.4% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 172 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 83%
Shared 17%
None 0%
Common Shares in VNDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $2,249,676,327 across 65 Biotechnology names. VNDA ranks #47 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,875,301 | $500,180,281 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
2,012,317 | $376,866,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,049 | $210,141,127 | |
| 4 | TECH |
BIO-TECHNE Corp
|
2,746,462 | $194,037,538 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
2,607,348 | $143,404,140 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
375,762 | $118,774,610 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
350,560 | $105,529,075 | |
| 8 | BNTX |
BioNTech SE
|
677,708 | $63,060,728 |
All Filings in VNDA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $601,870 | 98,345 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $696,203 | 100,753 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $912,393 | 103,446 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $692,636 | 138,805 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $835,676 | 177,050 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $802,602 | 174,859 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $856,677 | 178,847 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $863,808 | 184,181 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $560,357 | 136,340 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $576,633 | 136,643 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $608,942 | 140,959 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $964,512 | 146,360 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,017,203 | 149,809 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,138,377 | 154,043 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,489,726 | 150,782 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,658,511 | 152,157 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,712,209 | 151,389 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,350,911 | 149,835 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,620,191 | 152,870 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,331,382 | 154,876 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,258,300 | 83,775 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,289,874 | 98,164 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $957,798 | 99,151 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||